SARS-CoV-2 subunit protein recombinant vaccine

BIOLOGICAL2 trials

Sponsors

PT Bio Farma

Conditions

COVID-19

Phase 2

Booster Study of COVID-19 Protein Subunit Recombinant Vaccine

CompletedNCT05525208

PT Bio FarmaCOVID-19

Start: 2022-09-01End: 2023-08-04Updated: 2025-06-03

Heterologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine in Children 12-17 Years of Age

CompletedNCT05727215

PT Bio FarmaCOVID-19

Start: 2023-02-28End: 2024-03-18Updated: 2025-06-03